Oncology investment & partnering trends
Thursday, May 9th - 10:00 EDT | 15:00 BST | 16:00 CEST
Pharma investment in oncology is far and above all other therapeutic areas, with dealmaking and partnering a core strategy in that investment. In just the last 4 years, oncology deal values totaled a whopping $331 billion. From the top 20 pharma companies to small start-ups, oncology is pulling investment from across life sciences.
This webinar will dive into pharma’s largest sector to examine:
Sarah E. Hardison, Ph.D.
Therapeutic Area Director, Immunology & Immuno-oncology, Clarivate Analytics
Willie Reaves
Director, Partnering Products & Services, Biotechnology Innovation Organization (BIO)